The combination of a $25M PIPE from a reputable healthcare investor and ~$20.2M in insider purchases at the IPO price signals strong conviction in the IPO valuation. Traders should watch for the IPO pricing and any lock-up terms. The insider buying is highly material relative to market cap and suggests limited near-term downside risk at the IPO price.
Price Chart
Executive Summary
Odyssey Therapeutics insiders, including Director Li Nan and Director Chu Shelley, made open-market purchases totaling ~$20.2M on May 11, 2026, the same day a $25M PIPE investment from TPG LSI Rise Orazio II was disclosed in an 8-K. The PIPE is priced at the IPO price and closes concurrently with the IPO. The insider buying aligns with a major institutional commitment, signaling confidence in the IPO pricing and near-term prospects.
Key Financial Metrics
Key Facts
- Insider open-market purchases total ~$20.2M, representing ~2.6% of ODTX's $785M market cap.
- Director Li Nan purchased $20M worth of shares at $18/share.
- Director Chu Shelley purchased $200K worth of shares at $18/share.
- A $25M PIPE investment from TPG LSI Rise Orazio II was signed on May 7, 2026, priced at the IPO price.
- The PIPE closes concurrently with the IPO, indicating strong institutional backing.
- Multiple insiders converted derivatives (non-cash) on the same day, likely in preparation for the IPO.
- The insider cluster occurred within 1 day of the material agreement filing (8-K), which is an amplifier per cross-filing actuarial data.
Financial Impact
Insider purchases of ~$20.2M and a $25M PIPE investment, totaling ~$45.2M of new capital at the IPO price.
Risk Factors
- IPO pricing may be below the $18 insider purchase price if market conditions deteriorate.
- Post-IPO lock-up expirations could lead to selling pressure from converted derivatives.
- The company is pre-revenue (biotech), so clinical trial outcomes remain binary.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ODTX-1778621883698 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 6d ago | 8-K | $18.99 $19.00 | ▲ +0.05% | ▼ −0.47% | $19.30 (+1.63%) |
Aug 4, 2026 11w ago | 8-K | $19.96 $20.89 | ▲ +4.66% | ▲ +4.86% | $19.30 (−3.31%) |
Jun 17, 2026 18w ago | 8-K | $19.07 $18.72 | ▼ −1.84% | ▼ −1.52% | $19.30 (+1.21%) |
May 11, 2026 24w ago | Insider Cluster | $17.45 $17.90 | ▲ +2.58% | ▲ +2.72% | $19.30 (+10.60%) |
May 8, 2026 24w ago | 424B4 | $17.45 $17.90 | ▲ +2.58% | ▲ +2.72% | $19.30 (+10.60%) |
May 8, 2026 24w ago | EFFECT | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
May 7, 2026 24w ago | 3 | $16.42 $17.45 | ▲ +6.27% | ▲ +6.04% | $19.30 (+17.54%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers